{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T22:07:38Z","timestamp":1764194858452,"version":"3.37.0"},"reference-count":72,"publisher":"Bentham Science Publishers Ltd.","issue":"4","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CPB"],"published-print":{"date-parts":[[2025,1]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Microbial L-asparaginase (L-ASNase, EC 3.5.1.1) is a pivotal biopharmaceutical\ndrug-protein that catalyzes the hydrolysis of the non-essential amino acid L-asparagine\n(L-Asn) into L-aspartic acid (L-Asp) and ammonia , resulting in deplenishing the cellular L-Asn\npool, which leads to the ultimate death of the L-asparagine synthetase (L-ASNS) deficient cancerous\ncells.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objective:<\/jats:title>\n<jats:p>This study aimed to investigate the impact of conjugating low molecular weight polyethylene\nglycol to recombinant P. aeruginosa L-ASNase by examining the pharmacokinetic properties,\naffinity towards the substrate, and enzyme stability prior to and following the reaction.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>The recombinant P. aeruginosa L-ASNase was affinity purified and then PEGylated\nby attaching polyethylene glycol (MW= 330 Da) site-specifically to the protein's N-terminus\nend. After which, the PEGylated L-ASNase was examined by SDS-PAGE (15%), FTIR, and\nUV\/Vis spectrophotometry and subsequently biochemically characterized.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>The Km and Vmax values of free P. aeruginosa rL-ASNase were determined to be 0.318\n\u00b11.76 mM and 2915 \u03bcmol min-1and following the PEGylation, they were found to be 0.396 \u00b11.736\nmM and 3193 \u03bcmol min-1, respectively. Polyethylene glycol (330 Da) has markedly enhanced LASNase\nthermostability at 37, 45, 50, and 55\u00b0C, as opposed to the free enzyme, which retained\n19.5% after 1 h of incubation at 37\u00b0C. The PEGylated L-ASNase was found to be stable upon incubation\nwith human serum for 28 h, in contrast to the sharp decline in the residual bioactivity of\nthe free rL-ASNase after 4 h incubation. Accordingly, an in vivo study was used for validation, and\nit demonstrated that PEGylated rL-ASNase exhibited longer bioactivity for 24 h, while the free\nform's activity vanished entirely from the rats' blood sera after 8 h. Molecular dynamics simulation\nindicated that PEG (330 Da) has affected the hydrodynamic volume of L-ASNase and increased its\nstructural stability. Docking analysis has explored the position of PEG with respect to binding sites\nand predicted a similar binding affinity to that of the free enzyme.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>For the first time, recombinant L-ASNase was modified by covalently attaching\nPEG (330 Da). The resultant novel proposed PEGylated rL-ASNase with remarkably increased\nstability and prolonged in vivo half-life duration, could be considered an alternative to mitigate\nthe high molecular weight of PEGylation's drawbacks.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/0113892010309260240624072408","type":"journal-article","created":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T09:15:31Z","timestamp":1720775731000},"page":"617-629","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Pseudomonas aeruginosa Recombinant L-asparaginase: PEGylation with Low Molecular Weight Polyethylene Glycol, Molecular Dynamics Simulation, In vitro and In vivo Serum half-life and Biochemical Characterization"],"prefix":"10.2174","volume":"26","author":[{"given":"Rawan","family":"Alshamy","sequence":"first","affiliation":[{"name":"Department of Biotechnology, Institute of Graduate Studies and Research, Alexandria University, Alexandria, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nefertiti","family":"El-Nikhely","sequence":"additional","affiliation":[{"name":"Department of Biotechnology, Institute of Graduate Studies and Research, Alexandria University, Alexandria, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisham","family":"Nematalla","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology, Faculty of Pharmacy, Damanhur University, Damanhur, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed","family":"Elkewedi","sequence":"additional","affiliation":[{"name":"Department of Medical Laboratory Technology, Faculty of Applied Health Sciences Technology, Pharos University in\nAlexandria, Alexandria, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eman Abdallah","family":"Mahran","sequence":"additional","affiliation":[{"name":"Department of Biotechnology, Institute of Graduate Studies and Research, Alexandria University, Alexandria, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hesham","family":"Saeed","sequence":"additional","affiliation":[{"name":"Department of Biotechnology, Institute of Graduate Studies and Research, Alexandria University, Alexandria, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"902","DOI":"10.3390\/cancers14040902","volume":"14","author":"Van Trimpont M.","year":"2022","unstructured":"Van Trimpont M.; Peeters E.; De Visser Y.; Schalk A.M.; Mondelaers V.; De Moerloose B.; Lavie A.; Lammens T.; Goossens S.; Van Vlierberghe P.; Novel insights on the use of L-asparaginase as an efficient and safe anti-cancer therapy. Cancers (Basel)  2022,14(4),902","journal-title":"Cancers (Basel)"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"5335","DOI":"10.1007\/s00253-022-12086-8","volume":"106","author":"Darvishi F.","year":"2022","unstructured":"Darvishi F.; Jahanafrooz Z.; Mokhtarzadeh A.; Microbial L-asparaginase as a promising enzyme for treatment of various cancers. Appl Microbiol Biotechnol  2022,106(17),5335-5347","journal-title":"Appl Microbiol Biotechnol"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1016\/j.ijbiomac.2021.07.107","volume":"186","author":"Wang Y.","year":"2021","unstructured":"Wang Y.; Xu W.; Wu H.; Zhang W.; Guang C.; Mu W.; Microbial production, molecular modification, and practical application of L-asparaginase: A review. Int J Biol Macromol  2021,186,975-983","journal-title":"Int J Biol Macromol"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1002\/bab.1888","volume":"67","author":"Chand S.","year":"2020","unstructured":"Chand S.; Mahajan R.V.; Prasad J.P.; Sahoo D.K.; Mihooliya K.N.; Dhar M.S.; Sharma G.; A comprehensive review on microbial L -asparaginase: Bioprocessing, characterization, and industrial applications. Biotechnol Appl Biochem  2020,67(4),619-647","journal-title":"Biotechnol Appl Biochem"},{"key":"ref=5","first-page":"3076","volume":"2012","author":"Jha S.K.","year":"2012","unstructured":"Jha S.K.; Pasrija D.; Sinha R.; Singh H.; Kumar V.; Sharan N.; Vidyarthi A.; Microbial L-Asparaginase: A review on current scenario and future prospects. IJPSR  2012,2012,3076-3090","journal-title":"IJPSR"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"15220","DOI":"10.3390\/ijms242015220","volume":"24","author":"Shishparenok A.N.","year":"2023","unstructured":"Shishparenok A.N.; Gladilina Y.A.; Zhdanov D.D.; Engineering and expression strategies for optimization of l-asparaginase development and production. Int J Mol Sci  2023,24(20),15220","journal-title":"Int J Mol Sci"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"4515","DOI":"10.1007\/s00253-021-11359-y","volume":"105","author":"Castro D.","year":"2021","unstructured":"Castro D.; Marques A.S.C.; Almeida M.R.; de Paiva G.B.; Bento H.B.S.; Pedrolli D.B.; Freire M.G.; Tavares A.P.M.; Santos-Ebinuma V.C.; L-asparaginase production review: Bioprocess design and biochemical characteristics. Appl Microbiol Biotechnol  2021,105(11),4515-4534","journal-title":"Appl Microbiol Biotechnol"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"402","DOI":"10.3390\/metabo11060402","volume":"11","author":"Jiang J.","year":"2021","unstructured":"Jiang J.; Batra S.; Zhang J.; Asparagine: A metabolite to be targeted in cancers. Metabolites  2021,11(6),402","journal-title":"Metabolites"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"79","DOI":"10.17816\/onco562802","volume":"28","author":"Kislyak I.A.","year":"2023","unstructured":"Kislyak I.A.; Pokrovskaya M.V.; Zhanturina D.Y.; Pokrovsky V.S.; The use of L-asparaginase for the treatment of solid tumors: Data from experimental studies and clinical trials. Russian J Oncol  2023,28(1),79-94","journal-title":"Russian J Oncol"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1021\/acsptsci.0c00196","volume":"4","author":"Apfel V.","year":"2021","unstructured":"Apfel V.; Begue D.; Cordo\u2019 V.; Holzer L.; Martinuzzi L.; Buhles A.; Kerr G.; Barbosa I.; Naumann U.; Piquet M.; Ruddy D.; Weiss A.; Ferretti S.; Almeida R.; Bonenfant D.; Tordella L.; Galli G.G.; Therapeutic assessment of targeting ASNS combined with L -Asparaginase treatment in solid tumors and investigation of resistance mechanisms. ACS Pharmacol Transl Sci  2021,4(1),327-337","journal-title":"ACS Pharmacol Transl Sci"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1134\/S1990750823600541","volume":"17","author":"Kislyak I.A.","year":"2023","unstructured":"Kislyak I.A.; Pokrovsky V.S.; Biochemical markers of tumor cell sensitivity to L-asparaginase. Biochem Suppl Ser B: Biomed Chem  2023,17(3),111-125","journal-title":"Biochem Suppl Ser B: Biomed Chem"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"e0285948","DOI":"10.1371\/journal.pone.0285948","volume":"18","author":"Schnuchel A.","year":"2023","unstructured":"Schnuchel A.; Radcke C.; Theobald L.; Doeding S.; Quality comparison of a state-of-the-art preparation of a recombinant L-asparaginase derived from Escherichia coli with an alternative asparaginase product. PLoS One  2023,18(6),e0285948","journal-title":"PLoS One"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"1269282","DOI":"10.3389\/fmicb.2024.1269282","volume":"15","author":"Tsegaye K.","year":"2024","unstructured":"Tsegaye K.; Tsehai B.A.; Getie B.; Desirable L-asparaginases for treating cancer and current research trends. Front Microbiol  2024,15,1269282","journal-title":"Front Microbiol"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1007\/s40259-023-00622-5","volume":"37","author":"Miranda J.","year":"2023","unstructured":"Miranda J.; Lefin N.; Beltran J.F.; Bel\u00e9n L.H.; Tsipa A.; Farias J.G.; Zamorano M.; Enzyme engineering strategies for the bioenhancement of l-Asparaginase used as a biopharmaceutical. BioDrugs  2023,37(6),793-811","journal-title":"BioDrugs"},{"key":"ref=15","first-page":"130499","volume":"1858","author":"Tripathy R.K.","year":"2023","unstructured":"Tripathy R.K.; Anakha J.; Pande A.H.; Towards development of biobetter: L-asparaginase a case study. Biochim Biophys Acta  2023,1858(1),130499","journal-title":"Biochim Biophys Acta"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"113234","DOI":"10.1016\/j.colsurfb.2023.113234","volume":"225","author":"Monajati M.","year":"2023","unstructured":"Monajati M.; Tamaddon A.M.; Abolmaali S.S.; Yousefi G.; Javanmardi S.; Borandeh S.; Heidari R.; Azarpira N.; Dinarvand R.; L-asparaginase immobilization in supramolecular nanogels of PEG-grafted poly HPMA and bis(\u03b1-cyclodextrin) to enhance pharmacokinetics and lower enzyme antigenicity. Colloids Surf B Biointerfaces  2023,225,113234","journal-title":"Colloids Surf B Biointerfaces"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"108802","DOI":"10.1016\/j.bej.2022.108802","volume":"191","author":"Monajati M.","year":"2023","unstructured":"Monajati M.; Tamaddon A.M.; Abolmaali S.S.; Yousefi G.; Borandeh S.; Dinarvand R.; Enhanced L-asparaginase stability through immobilization in supramolecular nanogels of PEG-grafted poly HPMA with bis(\u03b1-cyclodextrin). Biochem Eng J  2023,191,108802","journal-title":"Biochem Eng J"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"200","DOI":"10.3390\/catal13010200","volume":"13","author":"Garcia P.H.D.","year":"2023","unstructured":"Garcia P.H.D.; Costa-Silva T.A.; G\u00f3mez M.M.; Contesini F.J.; Canella P.R.B.C.; Carvalho P.O.; Anticancer asparaginases: Perspectives in using filamentous fungi as cell factories. Catalysts  2023,13(1),200","journal-title":"Catalysts"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"212","DOI":"10.3389\/fbioe.2018.00212","volume":"6","author":"Brumano L.P.","year":"2019","unstructured":"Brumano L.P.; da Silva F.V.S.; Costa-Silva T.A.; Apolin\u00e1rio A.C.; Santos J.H.P.M.; Kleingesinds E.K.; Monteiro G.; Rangel-Yagui C.O.; Benyahia B.; Junior A.P.; Development of L-asparaginase biobetters: Current research status and review of the desirable quality profiles. Front Bioeng Biotechnol  2019,6,212","journal-title":"Front Bioeng Biotechnol"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"3387","DOI":"10.3390\/ijms24043387","volume":"24","author":"Xu M.","year":"2023","unstructured":"Xu M.; Bi J.; Liang B.; Wang X.; Mo R.; Feng N.; Yan F.; Wang T.; Yang S.; Zhao Y.; Xia X.; PEGylation prolongs the half-life of equine anti-SARS-CoV-2 Specific F(ab\u2019)2. Int J Mol Sci  2023,24(4),3387","journal-title":"Int J Mol Sci"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.jconrel.2014.02.002","volume":"180","author":"Pfister D.","year":"2014","unstructured":"Pfister D.; Morbidelli M.; Process for protein PEGylation. J Control Release  2014,180,134-149","journal-title":"J Control Release"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1002\/bit.25000","volume":"111","author":"Maiser B.","year":"2014","unstructured":"Maiser B.; Dismer F.; Hubbuch J.; Optimization of random PEGylation reactions by means of high throughput screening. Biotechnol Bioeng  2014,111(1),104-114","journal-title":"Biotechnol Bioeng"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"82","DOI":"10.3109\/07388551.2015.1120705","volume":"37","author":"Lopes A.M.","year":"2017","unstructured":"Lopes A.M.; Oliveira-Nascimento L.; Ribeiro A.; Tairum C.A.; Breyer C.A.; Oliveira M.A.; Monteiro G.; Souza-Motta C.M.; Magalh\u00e3es P.O.; Avenda\u00f1o J.G.F.; Cavaco-Paulo A.M.; Mazzola P.G.; Rangel-Yagui C.O.; Sette L.D.; Converti A.; Pessoa A.; Therapeutic L -asparaginase: Upstream, downstream and beyond. Crit Rev Biotechnol  2017,37(1),82-99","journal-title":"Crit Rev Biotechnol"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.jaip.2020.09.029","volume":"9","author":"Sellaturay P.","year":"2021","unstructured":"Sellaturay P.; Nasser S.; Ewan P.; Polyethylene glycol\u2013induced systemic allergic reactions (Anaphylaxis). J Allergy Clin Immunol Pract  2021,9(2),670-675","journal-title":"J Allergy Clin Immunol Pract"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1248\/bpb.b13-00661","volume":"37","author":"Zhang F.","year":"2014","unstructured":"Zhang F.; Liu M.; Wan H.; Discussion about several potential drawbacks of PEGylated therapeutic proteins. Biol Pharm Bull  2014,37(3),335-339","journal-title":"Biol Pharm Bull"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1111\/cea.13874","volume":"51","author":"Sellaturay P.","year":"2021","unstructured":"Sellaturay P.; Nasser S.; Islam S.; Gurugama P.; Ewan P.W.; Polyethylene glycol (PEG) is a cause of anaphylaxis to the Pfizer\/BioNTech mRNA COVID-19 vaccine. Clin Exp Allergy  2021,51(6),861-863","journal-title":"Clin Exp Allergy"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"e0211951","DOI":"10.1371\/journal.pone.0211951","volume":"14","author":"Meneguetti G.P.","year":"2019","unstructured":"Meneguetti G.P.; Santos J.H.P.M.; Obreque K.M.T.; Barbosa C.M.V.; Monteiro G.; Farsky S.H.P.; Marim de Oliveira A.; Angeli C.B.; Palmisano G.; Ventura S.P.M.; Pessoa-Junior A.; de Oliveira Rangel-Yagui C.; Novel site-specific PEGylated L-asparaginase. PLoS One  2019,14(2),e0211951","journal-title":"PLoS One"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s12079-018-0492-0","volume":"13","author":"Gupta V.","year":"2019","unstructured":"Gupta V.; Bhavanasi S.; Quadir M.; Singh K.; Ghosh G.; Vasamreddy K.; Ghosh A.; Siahaan T.J.; Banerjee S.; Banerjee S.K.; Protein PEGylation for cancer therapy: Bench to bedside. J Cell Commun Signal  2019,13(3),319-330","journal-title":"J Cell Commun Signal"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"e68559","DOI":"10.1371\/journal.pone.0068559","volume":"8","author":"Mu Q.","year":"2013","unstructured":"Mu Q.; Hu T.; Yu J.; Molecular insight into the steric shielding effect of PEG on the conjugated staphylokinase: Biochemical characterization and molecular dynamics simulation. PLoS One  2013,8(7),e68559","journal-title":"PLoS One"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"8415","DOI":"10.1002\/slct.201800855","volume":"3","author":"Sousa S.F.","year":"2018","unstructured":"Sousa S.F.; Peres J.; Coelho M.; Vieira T.F.; Analyzing PEGylation through molecular dynamics simulations. ChemistrySelect  2018,3(29),8415-8427","journal-title":"ChemistrySelect"},{"key":"ref=31","first-page":"1","author":"Sambrook T.","year":"1989","unstructured":"Sambrook T.; Fritsch J.; Maniatis T.;  Molecular cloning: A laboratory manual  1989,1","journal-title":"Molecular cloning: A laboratory manual"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"105820","DOI":"10.1016\/j.pep.2021.105820","volume":"181","author":"Saeed H.","year":"2021","unstructured":"Saeed H.; Hemida A.; Abdel-Fattah M.; Eldoksh A.; Shalaby M.; Nematalla H.; El-Nikhely N.; Elkewedi M.; Pseudomonas aeruginosa recombinant L-asparaginase: Large scale production, purification, and cytotoxicity on THP-1, MDA-MB-231, A549, Caco2 and HCT-116 cell lines. Protein Expr Purif  2021,181,105820","journal-title":"Protein Expr Purif"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","volume":"72","author":"Bradford M.M.","year":"1976","unstructured":"Bradford M.M.; A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem  1976,72(1-2),248-254","journal-title":"Anal Biochem"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1038\/227680a0","volume":"227","author":"Laemmli U.K.","year":"1970","unstructured":"Laemmli U.K.; Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature  1970,227(5259),680-685","journal-title":"Nature"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/0003-2697(92)90460-O","volume":"200","author":"Kurf\u00fcrst M.M.","year":"1992","unstructured":"Kurf\u00fcrst M.M.; Detection and molecular weight determination of polyethylene glycol-modified hirudin by staining after sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Anal Biochem  1992,200(2),244-248","journal-title":"Anal Biochem"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"S162","DOI":"10.1002\/elps.200900140","volume":"30","author":"Guex N.","year":"2009","unstructured":"Guex N.; Peitsch M.C.; Schwede T.; Automated comparative protein structure modeling with SWISS-MODEL and Swiss-PdbViewer: A historical perspective. Electrophoresis  2009,30(S1)(Suppl. 1),S162-S173","journal-title":"Electrophoresis"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"W296","DOI":"10.1093\/nar\/gky427","volume":"46","author":"Waterhouse A.","year":"2018","unstructured":"Waterhouse A.; Bertoni M.; Bienert S.; Studer G.; Tauriello G.; Gumienny R.; Heer F.T.; de Beer T.A.P.; Rempfer C.; Bordoli L.; Lepore R.; Schwede T.; SWISS-MODEL: Homology modelling of protein structures and complexes. Nucleic Acids Res  2018,46(W1),W296-W303","journal-title":"Nucleic Acids Res"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1186\/1471-2105-13-173","volume":"13","author":"Johansson M.U.","year":"2012","unstructured":"Johansson M.U.; Zoete V.; Michielin O.; Guex N.; Defining and searching for structural motifs using DeepView\/Swiss-PdbViewer. BMC Bioinformatics  2012,13(1),173","journal-title":"BMC Bioinformatics"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1002\/jcc.20090","volume":"25","author":"Oostenbrink C.","year":"2004","unstructured":"Oostenbrink C.; Villa A.; Mark A.E.; Van Gunsteren W.F.; A biomolecular force field based on the free enthalpy of hydration and solvation: The GROMOS force-field parameter sets 53A5 and 53A6. J Comput Chem  2004,25(13),1656-1676","journal-title":"J Comput Chem"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1021\/ct900549r","volume":"6","author":"Bjelkmar P.","year":"2010","unstructured":"Bjelkmar P.; Larsson P.; Cuendet M.A.; Hess B.; Lindahl E.; Implementation of the CHARMM force field in GROMACS: Analysis of protein stability effects from correction maps, virtual interaction sites, and water models. J Chem Theory Comput  2010,6(2),459-466","journal-title":"J Chem Theory Comput"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"9795","DOI":"10.1021\/jp2012842","volume":"115","author":"Qiu L.","year":"2011","unstructured":"Qiu L.; Buie C.; Reay A.; Vaughn M.W.; Cheng K.H.; Molecular dynamics simulations reveal the protective role of cholesterol in \u03b2-amyloid protein-induced membrane disruptions in neuronal membrane mimics. J Phys Chem B  2011,115(32),9795-9812","journal-title":"J Phys Chem B"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/978-1-4939-2269-7_19","volume":"1263","author":"Dallakyan S.","year":"2015","unstructured":"Dallakyan S.; Olson A.J.; Small-molecule library screening by docking with PyRx. Methods Mol Biol  2015,1263,243-250","journal-title":"Methods Mol Biol"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"e202201923","DOI":"10.1002\/chem.202201923","volume":"28","author":"Mil\u010di\u0107 N.","year":"2022","unstructured":"Mil\u010di\u0107 N.; Stepani\u0107 V.; Crnolatac I.; Findrik Bla\u017eevi\u0107 Z.; Brklja\u010da Z.; Majeri\u0107 Elenkov M.; Inhibitory effect of DMSO on halohydrin dehalogenase: Experimental and computational insights into the influence of an organic co-solvent on the structural and catalytic properties of a biocatalyst. Chemistry  2022,28(56),e202201923","journal-title":"Chemistry"},{"year":"2012","author":"Christopher Crafts I.A.","key":"ref=44","unstructured":"Christopher Crafts I.A.; Bailey B.; Plante M.; Analytical methods to characterize and quantify PEG and PEGylated biopharmaceuticals.  Available From:  https:\/\/assets.thermofisher.com\/TFS-Assets\/CMD\/posters\/pn-70052pegylatedbiopharmaceuticals-pittcon2012-pn70052-en.pdf2012"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"113082","DOI":"10.1016\/j.colsurfb.2022.113082","volume":"222","author":"Ferrado J.B.","year":"2023","unstructured":"Ferrado J.B.; Perez A.A.; Menegon M.; Vaillard V.A.; Gasser F.; Baravalle M.E.; Ortega H.H.; Vaillard S.E.; Santiago L.G.; PEGylation of genistein-loaded bovine serum albumin nanoparticles and its effect on in vitro cell viability and genotoxicity properties. Colloids Surf B Biointerfaces  2023,222,113082","journal-title":"Colloids Surf B Biointerfaces"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"2320","DOI":"10.1080\/10717544.2022.2100511","volume":"29","author":"Seo H.","year":"2022","unstructured":"Seo H.; Bae H.D.; Pyun H.; Kim B.G.; Lee S.I.; Song J.S.; Lee K.; Bae H.; Pyun B.; Kim S.; Lee K.; PEGylation improves the therapeutic potential of dimerized translationally controlled tumor protein blocking peptide in ovalbumin-induced mouse model of airway inflammation. Drug Deliv  2022,29(1),2320-2329","journal-title":"Drug Deliv"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"309","DOI":"10.15171\/apb.2016.043","volume":"6","author":"Akbarzadehlaleh P.","year":"2016","unstructured":"Akbarzadehlaleh P.; Mirzaei M.; Mashahdi-Keshtiban M.; Shamsasenjan K.; Heydari H.; PEGylated human serum albumin: Review of PEGylation, purification and characterization methods. Adv Pharm Bull  2016,6(3),309-317","journal-title":"Adv Pharm Bull"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1007\/s12010-021-03657-y","volume":"194","author":"Gurram S.","year":"2022","unstructured":"Gurram S.; Srivastava G.; Badve V.; Nandre V.; Gundu S.; Doshi P.; Pyridine borane as alternative reducing agent to sodium cyanoborohydride for the PEGylation of L-asparaginase. Appl Biochem Biotechnol  2022,194(2),827-847","journal-title":"Appl Biochem Biotechnol"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1111\/j.1423-0410.1979.tb02314.x","volume":"37","author":"Skoog B.","year":"1979","unstructured":"Skoog B.; Determination of polyethylene glycols 4000 and 6000 in plasma protein preparations. Vox Sang  1979,37(6),345-349","journal-title":"Vox Sang"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"6130","DOI":"10.1007\/s10853-020-04452-6","volume":"55","author":"Ulu A.","year":"2020","unstructured":"Ulu A.; Metal\u2013organic frameworks (MOFs): A novel support platform for ASNase immobilization. J Mater Sci  2020,55(14),6130-6144","journal-title":"J Mater Sci"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.molliq.2018.07.080","volume":"268","author":"de Lima G.F.","year":"2018","unstructured":"de Lima G.F.; de Souza A.G.; Rosa D.S.; Effect of adsorption of polyethylene glycol (PEG), in aqueous media, to improve cellulose nanostructures stability. J Mol Liq  2018,268,415-424","journal-title":"J Mol Liq"},{"key":"ref=52","doi-asserted-by":"publisher","DOI":"10.18332\/pht\/150224","volume":"2","author":"Dobryakova N.","year":"2022","unstructured":"Dobryakova N.; Zhdanov D.; Kudryashova E.; Preparation methods and biocatalytic properties of covalent conjugates of rhodospirillum rubrum l-asparaginase. Pub Health Toxicol  2022,2(Suppl. 2)","journal-title":"Pub Health Toxicol"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"120258","DOI":"10.1016\/j.molliq.2022.120258","volume":"366","author":"Savadkouhi N.","year":"2022","unstructured":"Savadkouhi N.; Salehi P.; Sepehri H.; Delphi L.; Rafati H.; Synthesis, characterization, and micelle formation of novel PEGylated derivatives of noscapine with anti-cancer activity. J Mol Liq  2022,366,120258","journal-title":"J Mol Liq"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.matlet.2019.03.071","volume":"246","author":"Li Y.","year":"2019","unstructured":"Li Y.; Wang Z.; Zhan Y.; Wang S.; Tao X.; Liao C.; Lu Z.; Improved mechanical and dielectric performances of epoxy nanocomposites filled with aminated polyethylene glycol grafted graphene. Mater Lett  2019,246,149-152","journal-title":"Mater Lett"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1016\/j.solmat.2011.01.022","volume":"95","author":"Karaman S.","year":"2011","unstructured":"Karaman S.; Karaipekli A.; Sar\u0131 A.; Bi\u00e7er A.; Polyethylene glycol (PEG)\/diatomite composite as a novel form-stable phase change material for thermal energy storage. Sol Energy Mater Sol Cells  2011,95(7),1647-1653","journal-title":"Sol Energy Mater Sol Cells"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"21932","DOI":"10.1038\/s41598-021-01126-4","volume":"11","author":"Oeller M.","year":"2021","unstructured":"Oeller M.; Sormanni P.; Vendruscolo M.; An open-source automated PEG precipitation assay to measure the relative solubility of proteins with low material requirement. Sci Rep  2021,11(1),21932","journal-title":"Sci Rep"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1080\/00032711003789959","volume":"44","author":"Gonz\u00e1lez-Valdez J.","year":"2011","unstructured":"Gonz\u00e1lez-Valdez J.; Rito-Palomares M.; Benavides J.; Quantification of RNase A and its PEGylated conjugates on polymer-salt rich environments using UV spectrophotometry. Anal Lett  2011,44(5),800-814","journal-title":"Anal Lett"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"4432","DOI":"10.1039\/C9TB00590K","volume":"7","author":"Santos J.H.P.M.","year":"2019","unstructured":"Santos J.H.P.M.; Carretero G.; Ventura S.P.M.; Converti A.; Rangel-Yagui C.O.; PEGylation as an efficient tool to enhance cytochrome c thermostability: A kinetic and thermodynamic study. J Mater Chem B Mater Biol Med  2019,7(28),4432-4439","journal-title":"J Mater Chem B Mater Biol Med"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2022\/8929715","volume":"2022","author":"Zuma L.K.","year":"2022","unstructured":"Zuma L.K.; Gasa N.L.; Makhoba X.H.; Pooe O.J.; Protein PEGylation: Navigating recombinant protein stability, aggregation, and bioactivity. BioMed Res Int  2022,2022,1-7","journal-title":"BioMed Res Int"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1007\/s10529-009-9947-y","volume":"31","author":"Rodr\u00edguez-Mart\u00ednez J.A.","year":"2009","unstructured":"Rodr\u00edguez-Mart\u00ednez J.A.; Rivera-Rivera I.; Sol\u00e1 R.J.; Griebenow K.; Enzymatic activity and thermal stability of PEG-\u03b1-chymotrypsin conjugates. Biotechnol Lett  2009,31(6),883-887","journal-title":"Biotechnol Lett"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.ijpharm.2017.01.040","volume":"519","author":"Morgenstern J.","year":"2017","unstructured":"Morgenstern J.; Baumann P.; Brunner C.; Hubbuch J.; Effect of PEG molecular weight and PEGylation degree on the physical stability of PEGylated lysozyme. Int J Pharm  2017,519(1-2),408-417","journal-title":"Int J Pharm"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1016\/j.procbio.2015.04.024","volume":"50","author":"Hsieh Y.P.","year":"2015","unstructured":"Hsieh Y.P.; Lin S.C.; Effect of PEGylation on the activity and stability of horseradish peroxidase and l-N-carbamoylase in aqueous phases. Process Biochem  2015,50(9),1372-1378","journal-title":"Process Biochem"},{"key":"ref=63","doi-asserted-by":"publisher","DOI":"10.11606\/D.9.2021.tde-05082021-101113","author":"Cunha J.R.","year":"2021","unstructured":"Cunha J.R.; Effects of site-directed PEGylation on L-asparaginase thermostability., Disserta\u00e7\u00e3o de Mestrado, Faculdade de Ci\u00eancias Farmac\u00eauticas  2021","journal-title":"Disserta\u00e7\u00e3o de Mestrado, Faculdade de Ci\u00eancias Farmac\u00eauticas"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1080\/21691401.2022.2126851","volume":"50","author":"Ryu J.","year":"2022","unstructured":"Ryu J.; Yang S.J.; Son B.; Lee H.; Lee J.; Joo J.; Park H.H.; Park T.H.; Enhanced anti-cancer effect using MMP-responsive L-asparaginase fused with cell-penetrating 30Kc19 protein. Artif Cells Nanomed Biotechnol  2022,50(1),278-285","journal-title":"Artif Cells Nanomed Biotechnol"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.joca.2022.09.010","volume":"31","author":"He T.","year":"2023","unstructured":"He T.; Zhang C.; Colombani T.; Bencherif S.A.; Porter R.M.; Bajpayee A.G.; Intra-articular kinetics of a cartilage targeting cationic PEGylated protein for applications in drug delivery. Osteoarthritis Cartilage  2023,31(2),187-198","journal-title":"Osteoarthritis Cartilage"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s11095-019-2745-x","volume":"37","author":"Al Shoyaib A.","year":"2020","unstructured":"Al Shoyaib A.; Archie S.R.; Karamyan V.T.; Intraperitoneal route of drug administration: Should it be used in experimental animal studies? Pharm Res  2020,37(1),12","journal-title":"Pharm Res"},{"key":"ref=67","first-page":"562","volume":"1971","author":"Brindle D.","year":"1971","unstructured":"Brindle D.; Haven N.; The route of absorption of intraperitoneally adminestrated compounds. J Pharmacol Exp Ther  1971,1971,562-566","journal-title":"J Pharmacol Exp Ther"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1002\/jat.727","volume":"21","author":"Diehl K.H.","year":"2001","unstructured":"Diehl K.H.; Hull R.; Morton D.; Pfister R.; Rabemampianina Y.; Smith D.; Vidal J.M.; Vorstenbosch C.V.D.; A good practice guide to the administration of substances and removal of blood, including routes and volumes. J Appl Toxicol  2001,21(1),15-23","journal-title":"J Appl Toxicol"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.procs.2019.08.181","volume":"156","author":"Arnittali M.","year":"2019","unstructured":"Arnittali M.; Rissanou A.N.; Harmandaris V.; Structure of biomolecules through molecular dynamics simulations. Procedia Comput Sci  2019,156,69-78","journal-title":"Procedia Comput Sci"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/07391102.2020.1794974","volume":"39","author":"Rahman M.M.","year":"2020","unstructured":"Rahman M.M.; Saha T.; Islam K.J.; Suman R.H.; Biswas S.; Rahat E.U.; Hossen M.R.; Islam R.; Hossain M.N.; Al Mamun A.; Khan M.; Ali M.A.; Halim M.A.; Virtual screening, molecular dynamics, and structure\u2013activity relationship studies to identify potent approved drugs for Covid-19 treatment. J Biomol Struct Dyn  2020,39(16),1-11","journal-title":"J Biomol Struct Dyn"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"2585","DOI":"10.1021\/bi101926u","volume":"50","author":"Yang C.","year":"2011","unstructured":"Yang C.; Lu D.; Liu Z.; How PEGylation enhances the stability and potency of insulin: A molecular dynamics simulation. Biochemistry  2011,50(13),2585-2593","journal-title":"Biochemistry"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"5196","DOI":"10.1021\/acs.jpcb.8b12268","volume":"123","author":"Munasinghe A.","year":"2019","unstructured":"Munasinghe A.; Mathavan A.; Mathavan A.; Lin P.; Colina C.M.; Molecular insight into the protein\u2013polymer interactions in N-Terminal PEGylated bovine serum albumin. J Phys Chem B  2019,123(25),5196-5205","journal-title":"J Phys Chem B"}],"container-title":["Current Pharmaceutical Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0113892010309260240624072408","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/231884\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0113892010309260240624072408","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T12:59:46Z","timestamp":1739451586000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/231884\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":72,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0113892010309260240624072408","relation":{},"ISSN":["1389-2010"],"issn-type":[{"type":"print","value":"1389-2010"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2024-03-14","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-05-08","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-05-17","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-01-01","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}